DCGI
India’s first intra-nasal Corona vaccine: GK & Current Affairs Facts
The country’s first intranasal COVID vaccine iNCOVACC by Bharat Biotech has recently received DCGI approval for primary immunization against the infection for people above the age of 18 years. This vaccine has been named ChAd36-SARS-CoV-S COVID-19. Highlights ChAd36-SARS-CoV-S COVID-19 (Chimpanzee ..
Month: Current affairs - September, 2022
Category: Science & Technology Current Affairs
2DG- DRDO’s Anti-Covid Drug
On May 17, 2021, the DRDO released the first batch of 2-DG drugs. The 2-DG was developed by the Defence Research Development Organisation for Emergency Use. 2-DG is 2-Deoxy – D – Glucose. It is to be provided as a ..
Month: Current Affairs - May, 2021
Indian Company Zydus Cadila Starts Clinical Trial for COVID 19 Vaccine
The Indian pharmaceutical behemoth, Zydus Cadila, has started the Phase I, II clinical trials for its COVID 19 vaccine. The pharma giant had received approval from the Drug Controller General of India for clinical trials earlier this month. The company ..
Month: Current Affairs - July, 2020
First indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine Approved by DCGI
The first-ever completely home-grown Pneumococcal Polysaccharide Conjugate Vaccine has been approved by the Drug Controller General of India. The vaccine has been developed by Serum Institute of India, Pune. Serum Institute of India is also involved in the development of ..
Month: Current Affairs - July, 2020
DCGI allows use of “Itolizumab” for moderate to severe COVID-19 cases
On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal antibody that was already approved for chronic plaque psoriasis. The drug will ..
Month: Current Affairs - July, 2020
CSIR: Clinical Trial of “Sepsivac” drug on critically ill COVID-19 patients
On April 22, 2020, the Council of Scientific and Industrial Research announced that it is to go for clinical trials on critically ill COVID-19 patients. Background The Drugs Controller General of India recently approved the trial of “Sepsivac”. The drug ..